30 Recruiting Biliary Tract Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Biliary Tract Cancer
Related Conditions
Top Recruiting Biliary Tract Cancer Studies
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
📍 The University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
📍 Research Site — Mobile, Alabama
View Study & Checklist ➔XmAb20717 in Advanced Biliary Tract Cancers
📍 Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
📍 Maryland Proton Treatment Center — Baltimore, Maryland
View Study & Checklist ➔Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
📍 Sarah Cannon Research Institute — Denver, Colorado
View Study & Checklist ➔Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
📍 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
📍 City of Hope(City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
View Study & Checklist ➔Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
📍 Research Site — Scottsdale, Arizona
View Study & Checklist ➔